Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Medicine information COMIRNATY COVID-19 VACCIN 10mcg / dose concentrate for dispersion for injection
- Product code:
- W68305001
- Quantity:
- 10
- Indicated for:
- COVID-19
- Route of administration:
- injectable
- Substance:
- COVID-19 mRNA vaccine (with modified nucleosides) (vaccine)
- ATC
- J07BX03 — Antiinfectives for systemic use | Viral vaccines | Other viral vaccines
mRNA COVID-19 vaccines (with modified nucleosides) are used to prevent infection with the SARS-CoV-2 virus, which causes COVID-19. These vaccines contain a fragment of messenger RNA (mRNA) that encodes the virus's spike protein. After administration, host cells use the mRNA to produce the spike protein, which stimulates the immune system to generate an immune response, including specific antibodies.
mRNA vaccines are administered intramuscularly, usually in two doses, spaced 3-4 weeks apart, depending on the manufacturer. They are recommended for all eligible age groups, including individuals at high risk of severe COVID-19 complications.
Common side effects include pain at the injection site, fatigue, fever, muscle aches, and headaches. In rare cases, severe adverse reactions such as myocarditis, pericarditis, or allergic reactions may occur.
mRNA COVID-19 vaccines represent a major innovation in vaccinology, providing effective protection against SARS-CoV-2 infection and reducing the severity of the disease and associated complications.
mRNA vaccines are administered intramuscularly, usually in two doses, spaced 3-4 weeks apart, depending on the manufacturer. They are recommended for all eligible age groups, including individuals at high risk of severe COVID-19 complications.
Common side effects include pain at the injection site, fatigue, fever, muscle aches, and headaches. In rare cases, severe adverse reactions such as myocarditis, pericarditis, or allergic reactions may occur.
mRNA COVID-19 vaccines represent a major innovation in vaccinology, providing effective protection against SARS-CoV-2 infection and reducing the severity of the disease and associated complications.
General data about COMIRNATY COVID-19 VACCIN 10mcg / dose
- Substance:
- COVID-19 mRNA vaccine (with modified nucleosides)
- Date of latest medicines list:
- 01-01-2022
- Product code:
- W68305001
- Strength:
- 10mcg / dose
- Pharmaceutical form:
- concentrate for dispersion for injection
- Pack volume:
- 1,3 ml
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for COVID-19 mRNA vaccine (with modified nucleosides)
Strengths available for COVID-19 mRNA vaccine (with modified nucleosides)
- 100mcg/dose
- 10mcg/dose
- 30mcg/dose
- 50mcg/dose
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
- Added to database:
- 12/01/2021
- Source record updated:
- 06/08/2026
Warnings:
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.